Gum Health in Adults Seeking Weight-Loss Surgery
Studies gum disease and saliva markers in adults with obesity considering bariatric surgery.
Plain-language title generated from the registry record
Registry title: Periodontal Assessment of a Bariatric Care Population
Key facts
- Where
- London and Luton, United KingdomSee the 4 sites
Where in United Kingdom
- Barts Health NHS Trust Dental HospitalLondon, United KingdomTaking people
- Centre for Oral Clinical Research (COCR)London, United KingdomTaking people
- St Bartholomew's Hospital, Barts Health NHS TrustLondon, United KingdomTaking people
- Luton and Dunstable University HospitalLuton, United KingdomTaking people
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Trial details
- Who runs it
- Queen Mary University of London
- Trial code
- NCT04851470
- Record updated
- 2 July 2026
- Original description
Our primary aim is to investigate the prevalence and severity of Periodonotal Disease (PD) in a population of obese patients.Read full original descriptionShow less
Periodontal Assessment of a Bariatric Care Population, Clinical, Genetic and Microbiological Characteristics. A Cross-sectional Study.
Our primary aim is to investigate the prevalence and severity of Periodonotal Disease (PD) in a population of obese patients.
Our secondary objectives are to:
Investigate inflammatory biomarkers that have been associated with PD in the saliva of obese patients.
Investigate the association of FTO gene (Obesity) polymorphisms with the prevalence of PD in this population.
Investigate and describe the subgingival microbial flora in obese patients with PD from subgingival dental plaque samples as well as the salivary samples.
Inclusion: Each subject must meet all of the following inclusion criteria to be enrolled in the study:; Subject must be over 18 years of age; Subject must have a BMI of higher or equal to 30 kg/ m2; Subject must have voluntarily given written informed consent.
Exclusion: Subject is currently involved in other research involving the use of antibiotics or novel or unknown medications; Subject is on chronic treatment (i.e., two weeks or more) with specific medications known to affect periodontal status (phenytoin or cyclosporine) within one month of baseline visit; Subjects on chronic antibiotic therapy (ie two weeks or more in the previous month); Subject knowingly has HIV or Viral Hepatitis; Subject with uncontrolled systemic illnesses; Subjects meeting any of the following exclusion criteria are not to be enrolled in the study:; Self-reported pregnancy; Patients are completely edentulous; Subject is not capable to give informed consent.